A genetic mutation present in 10-20% of people in countries like Spain, Portugal, Italy and Israel may translate to higher skin cancer risk.
Multiple sclerosis patients were shown to have increased risk of developing cancer, especially breast cancer. This contradicts earlier studies and requires additional research.
Women over 50 not screened for cervical cancer have 6 times the risk to be diagnosed in later life.
Combining standard 2nd-line chemotherapy with the targeted therapy ramucirumab improves survival, quality of life for patients with metastatic gastric cancer.
Metastatic pancreatic ductal adenocarcinoma patients treated with 2 different anti-cancer vaccines had improved survival compared to treatment with only 1 of them.
Promising interim results of a new chemotherapy combination against with advanced neuroendocrine tumors show promise during a trial, for 95% of patient group.
Stage 2 or 3 rectal cancer patients treated with combining pre-operative radiation with either capecitabine or 5-fluorouracil (5-FU) had equivalent outcomes.
Genetic RAS mutations can help predict response to second-line treatment for metastatic colorectal cancer with panitumumab, based on a phase 3 clinical trial.
Progress in radiation therapy technology can reduce its impact on tissue surrounding the tumor, and also lower the total radiation dose.
Lynch syndrome is an inherited disease that increases the risk of various tumors. Researchers refined the prediction methods of colon and endometrial cancers, among others.
The mechanism of premature cell aging can help treat cancer. Treatments for acute promyelocytic leukemia cause similar effects which can be used for other cancers as well, according to the latest research on this rare type of blood cancer.
Adults who have survived pediatric cancer need ongoing care, which many internists feel not well-equipped to provide, as shown by a recent study.
Some of the latest prostate cancer drugs target a type of cells which may not be driving the tumor's growth, as previously thought.
Chemotherapy after surgery (called adjuvant chemotherapy) for breast cancer should not be delayed for more than 60 days.
Latest research on cervical cancer identified a gene as a potential target to stop the tumor's growth. This development may improve future treatment options.
Advanced surgery techniques for identifying cancerous brain cells may improve outcomes for glioblastoma multiforme patients, a tumor with usually poor prognosis.
Lung and bladder cancer biomarker analysis have similar genetic abnormalities. This latest research may have diagnostic, prognostic and treatment implications.
New hope for a potential cure for triple negative breast cancer came from a recent discovery of an engineered virus against these tumor cells.
A pediatric cancer review reports 175,000 annual worldwide diagnoses for children up to 15 years of age. Also, 1 in 285 will receive the diagnosis before the age of 20.
An alarming finding indicates that antioxidants may speed up lung cancer’s progression, instead of halting it (as shown previously). Antioxidants are chemicals present in some pharmaceuticals, foods and nutritional supplements.
An experimental breast cancer drug by Pfizer significantly delayed progression of symptoms in a mid-stage trial, as tested in post-menopausal women with locally advanced or newly diagnosed disease that had spared to other parts of the body.
Higher levels of the protein vascular endothelial growth factor (VEGF) in blood was linked to poor response to ipilimumab immunotherapy skin cancer treatment.
Renal cell carcinoma (RCC) advances require more emphasis on molecular biology and genetics, according to a researcher at the Genitourinary Cancers Symposium.
Androgen and vitamin D receptors were found as possible targets for breast cancer treatment, beyond estrogens which are the focus of current such treatments.
3D mapping biopsies for prostate cancer were found more effective in location tumors, and a new study reports the locations that ultrasound-guided biopsies miss.
Between 1970-2009, skin cancer in adults 40-60 years old has become 8 times more common. Women between 40-50 showed the highest increase among any demographic.
Research after lumpectomy showed that older breast cancer patients were more likely to undergo mastectomy after brachytherapy, compared to radiation therapy. However, they fared better than those who did not receive any radiation.
Daily aspirin intake reduced ovarian cancer risk by 20% in a study, raising prevention hopes. Clinical recommendations must be based on further research, though.
A study of the entire DNA (whole genome testing) among 400 women with advanced breast cancer may help doctors identify optimal treatments based on genetics.
An analysis has confirmed the importance of known prognostic factors for the long-term outcome in treatment with pazopanib for metastatic soft tissue sarcoma.